Mechanism of Inhibitory Action of Cyclooxygenase-2 Inhibitors in Human Platelets

Research Article
Mechanism of Inhibitory Action of Cyclooxygenase-2 Inhibitors in Human Platelets

S.A. Saeed, H. Rasheed, T.M. Ali, Y. Qazi, S. Kabraji, L. Paul, R. Khan, F.A. Hussain and S. Ahmad

Journal of Biological Sciences, 2004, 4(4), 515-520.

Abstract

This study was conducted to investigate the effects of nimesulide in platelet aggregation. It shows that nimesulide (1-100 μ M) inhibited platelets aggregation induced by adrenaline, (20-200 μ M). It also inhibed thromboxane A₂ (TXA₂) formation by platelets at low concentration (IC₅₀; 1 μ M). However, much lower concentrations of nimesulide (0.01-0.1 μ M) potentiated the aggregatory response of subthreshold concentrations of adrenaline (0.2-2 μ M). Such an effect was blocked by Ca²⁺-channel blockers, verapamil and diltiazem (IC₅₀: 7 and 46 μ M, respectively), nitric oxide donor, SNAP (IC₅₀: 2 μ M) and cinchonine (10 nM) but not by genistein (up to 10 μ M). These results are indicative of the concentration-dependent dual effects of nimesulide on human platelet aggregation. The synergistic effect of low doses of nimesulide and adrenaline seems to be mediated through inhibition of multiple signaling pathways.

ASCI-ID: 38-922

Cited References Fulltext

Cited By

Reduction in Platelet Aggregation (in vitro) by Diallyl Sulphide in Female Participants with Type 2 Diabetes Mellitus

Journal of Pharmacology and Toxicology, 2011, 6(4), 381. DOI: 10.3923/jpt.2011.381.390

Multiple pathways are responsible for Anti-inflammatory and Cardiovascular activities of Hordeum vulgare L.

Journal of Translational Medicine, 2014, 12(1), . DOI: 10.1186/s12967-014-0316-9